Financials data is unavailable for this security.
Cash flow in CNYView more
In 2024, cash reserves at Sunho Biologics Inc fell by 46.08m. Cash Flow from Financing totalled 406.53m or -- of revenues. In addition the company used 109.02m for operations while cash used for investing totalled 345.04m.
| Cash flow per share | -0.5435 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.48 |
|---|---|
| Tangible book value per share | 3.41 |
More ▼
Balance sheet in CNYView more
| Current ratio | 6.59 |
|---|---|
| Quick ratio | 6.57 |
| Total debt/total equity | 0.1418 |
|---|---|
| Total debt/total capital | 0.1242 |
More ▼
